Stefan Grudén

Title: Stefan Grudén and His Pharmaceutical Invention.

Introduction

Stefan Grudén is an inventor associated with Uppsala, Sweden, and Vicore Pharma AB. His patent work concerns a pharmaceutical dosage form designed for peroral administration.

Latest Patents

The supplied information lists one patent for Grudén: “Dry powder composition for peroral administration.” The invention describes a capsule containing a particulate pharmaceutical mixture with the compound C21, or a pharmaceutically acceptable salt, blended with carrier particles and a glidant. The carrier particles are selected to have particle size and density characteristics similar to those of the C21 particles. Preferred materials include mannitol as a carrier and colloidal silica as a glidant.

The dosage form is described as potentially useful in treating lung diseases, including idiopathic pulmonary fibrosis, sarcoidosis, and respiratory virus-induced tissue damage. Grudén’s reported patent count is 1 patent.

Career Highlights

Grudén’s listed invention focuses on the formulation and delivery of a pharmaceutical compound, with attention to the properties of the powder mixture and its suitability for capsule-based oral administration. The supplied information associates him with Vicore Pharma AB.

Collaborations

The supplied information names Ola Camber and Arnout Everaert as Grudén’s coworkers. It does not specify their roles in the patent or describe particular collaborative contributions.

Conclusion

Stefan Grudén’s listed patent reflects work on a specialized oral powder formulation intended to support the delivery of C21 and its potential use in treating lung diseases.